Powered by Clearbit
Pharmicell Co., Ltd. (NL: )+ to Company Analysis List
Address: 874, Eonju-ro, Gangnam-gu,Daejeon, 06017 Korea (South)  |  Phone: (82) 2 3496 0114  |  Fax: (82) 2 3496 0149  |  Company Website: www.pharmicell.com

Incorporated: August 1968 , Korea (South)

CINS: Y2475B10

Auditor: Shinseung Accounting Corporation

Country: Korea (South)

Industry: Biotechnology (ICB 20103010)

Industry: Women's and misses' outerwear, nec (SIC 2339)

Industry: Cut and Sew Apparel Manufacturing (except Contractors) (NAICS 315250)

Number of Employees: 120 (Total Full-Time as of 12/31/2018)

Revenue: 28,351,801,126

Net Income: -12,680,884,168

EPS Basic: -214.00000000    EPS Diluted: -214.00000000

As reported Prelims Standardized Restated Ratios Analysis
Include Auditor Data within Download   Download  Printer Friendly My Mergent Tools
Company Analysis List (0/500)
No company added to the Company Analysis List
Executive List (0/500)
No executive added to the Executive List
Mergent Private Company List (0/500)
No company added to the Mergent Private Company List
Company Alerts (0)
No alerts added to Alerts
Executive Alerts (0)
No alerts added to Executive Alerts
      Show Footnotes

      
Due to changes with International Financial Reporting Standards (IFRS), recent financials statement presentations have been adjusted to meet this standard. Please note the original historical presentations have remained in the original format
Exchange rate used is that of the Year End reported date
As Reported Annual Balance Sheet
Report Date12/31/201812/31/201712/31/201612/31/201512/31/2014
CurrencyKRWKRWKRWKRWKRW
Audit StatusNot QualifiedNot QualifiedNot QualifiedNot QualifiedNot Qualified
ConsolidatedNoNoNoNoNo
ScaleThousandsThousandsThousandsThousandsThousands
Total current assets32,533,270.14725,850,467.16830,528,712.72925,769,128.10732,204,087.828
Cash & cash equivalents18,588,564.59613,016,123.96411,850,245.09414,118,445.62622,175,631.518
Trade receivables, gross6,869,4497,245,75311,712,39711,135,7839,073,991
Allowance for bad & doubtful debts, trade(825,023)(828,999)(4,924,833)(4,715,905)(3,976,508)
Trade receivables, net----5,097,483
Other receivables, gross38,550168,4671,054,4371,709,1531,631,309
Allowance for bad & doubtful debts, other(26,241)(14,000)(927,642)(1,241,154)(784,710)
Accrued income, gross17,62217,19516,402167,088-
Allowance for bad & doubtful debts, accrued income---(118,438)-
Accrued income, net----30,142
Trade & other receivables, net6,074,357.7496,588,416.4316,930,761.2626,936,526.8655,974,224.08
Other financial assets2,064,311.039337,716.127,172,941.2781,258,347.432350,047.95
Inventories5,375,625.3225,439,528.2553,901,372.0332,791,820.6542,588,109.571
Other current assets405,514.751445,601.518644,320.482629,160.581,102,242.299
Current tax receivables24,896.6923,080.8829,072.5834,826.9513,832.41
Total non-current assets26,583,865.87537,901,474.65171,424,637.13276,332,204.25466,640,577.218
Investments available-for-sale---4,999,851.191-
Other financial assets2,00046,688.9574,216.8286,661.5239,140.75
Investment property107,000107,000174,232.2174,232.2174,232.2
Property, plant & equipment, gross23,672,77319,241,37117,211,02714,861,1589,316,780
Accumulated depreciation & amortization(5,546,239)(4,629,866)(5,836,232)(5,363,391)(4,804,551)
Government grants-(8,666)---
Property, plant & equipment, net18,126,536.28814,602,838.27411,374,795.3479,497,766.1264,512,229.078
Goodwill, net5,542,70716,037,26519,550,66419,550,664-
Other intangible assets, net1,187,9736,188,52339,286,56940,642,064-
Intangible assets, net6,730,680.24422,225,787.33758,837,232.67560,192,727.60760,444,949.58
Other non-current assets1,617,649.343919,160.09964,160.091,380,965.611,470,025.61
Total assets59,117,136.02263,751,941.819101,953,349.861102,101,332.36198,844,665.046
Total current liabilities3,321,879.4382,380,848.9391,821,952.2145,845,993.15211,261,445.158
Trade payables1,063,890718,890401,7711,073,785312,833
Other payables1,055,760993,688713,902752,471881,525
Trade & other payables2,119,649.3121,712,578.1651,115,672.6961,826,255.541,194,358.017
Short-term borrowings----1,500,000
Other financial liabilities57,180.104----
Convertible bonds---3,010,454.8047,492,167.367
Other current liabilities1,145,050.022668,270.774706,279.5181,009,282.8081,074,919.774
Total non-current liabilities8,305,211.095,377,921.4755,536,338.9544,910,925.5724,181,398.668
Long-term borrowings3,000,000396,000---
Post-employment benefit obligation4,601,540.4594,230,356.2274,701,738.9714,035,837.1993,281,490.723
Other non-current liabilities703,670.631751,565.248834,599.983875,088.373899,907.945
Total liabilities11,627,090.5287,758,770.4147,358,291.16810,756,918.72415,442,843.826
Equity attributable to controlling interest----83,401,821.22
Share capital29,979,47529,204,05529,191,30528,616,861.526,329,346
Capital surplus188,342,289.616179,893,649.43179,779,001.43175,943,364.546164,267,137.195
Other equity(43,340.174)2,893,889.7222,917,528.2222,944,971.6872,182,432.701
Retained earnings (accumulated deficit)(170,788,379.148)(155,998,422.747)(117,292,775.959)(116,160,784.096)(109,377,094.676)
Total equity47,490,045.49455,993,171.40594,595,058.69391,344,413.63783,401,821.22
Total equity & liabilities59,117,136.02263,751,941.819101,953,349.861102,101,332.36198,844,665.046